Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000215457-17-002150
Filing Date
2017-01-30
Accepted
2017-01-30 11:29:26
Documents
1

Document Format Files

Seq Description Document Type Size
1 aptevo.therapeutics..txt SC 13G 11326
  Complete submission text file 0000215457-17-002150.txt   13053
Mailing Address 55 EAST 52ND STREET NEW YORK NY 10055
Business Address 55 EAST 52ND STREET NEW YORK NY 10055 212-810-5300
BlackRock Inc. (Filed by) CIK: 0001364742 (see all company filings)

EIN.: 320174431 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6211 Security Brokers, Dealers & Flotation Companies

Mailing Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121
Business Address 2401 4TH AVE. SUITE 1050 SEATTLE WA 98121 206-838-0500
Aptevo Therapeutics Inc. (Subject) CIK: 0001671584 (see all company filings)

EIN.: 811567056 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-89584 | Film No.: 17555906
SIC: 2834 Pharmaceutical Preparations